hotspot -WSS

hotspot

author：comprehensive 2025-09-27 13:09:39 - browse：52954

Cambridge: Biogen — Ruby Wallau for STAT

Biogen, the iconic but embattled biotech firm, is shuttering Biogen Digital Health, its roughly 150-person group focused on using new types of data like those from mobile phones and smart watches, and ending a clinical trial being conducted with Apple early, STAT has learned.

Biogen confirmed the organizational change, but said it might lean even more on digital tech startups in the future.

“It’s certainly not an abandonment of digital, it’s more of a realignment of resources and priorities,” said Adam Keeney, Biogen’s executive vice president and head of corporate development. However, he later acknowledged, Biogen Digital Health, a separate entity, “would no longer continue in its current form.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Psilocybin's anti

WSS

As pharma fights Medicare drug negotiation, hospitals, docs silent

Study points to new risk in gene therapy death of Terry Horgan

Study points to new risk in gene therapy death of Terry Horgan

Health insurers' Q3 question: how much care are people getting?

The United States is paying nearly triple for new Covid vaccines

2024 GOP presidential candidates spar over abortion in debate

entertainment

hotspot

leisure time

Cancer drug shortages should be causing more outrage

Appeals court upholds limits to abortion pill

Guidelines to prevent youth baseball injuries need more muscle

Setback for rare diseases as Taysha Gene Therapies pulls back

At least 13 dead in Texas as scorching temps continue

How to make AI work for medicine

Continuity nursing helped my family in our darkest PICU moments

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

DIEP, the 'gold standard' of breast reconstruction, is under threat

What will Novo Nordisk's VC do with its influx of cash?

leisure time

WHO recommends second malaria vaccine

Lawsuit highlights wrinkle for disputes over surprise medical bills

The biotech scorecard for Q4: 16 stock

The Karikó problem: Lessons for funding basic research

The stability of $0 premiums in Medicare Advantage

Study finds new variant for Parkinson’s in African populations

hotspot

focus

leisure time

knowledge